Lhasa Limited shared knowledge shared progress

Archive

This is a library of Lhasa's blog articles. 

  • 10 tips 
for controlling 
your potentially mutagenic impurities outside the lab.
    Clock: less than 5 minutesless than 5 minutes

    10 tips for controlling your potentially mutagenic impurities outside the lab

    Many readers of this blog will be aware of the threat posed by potentially mutagenic impurities within drug substance synthesis. Such impurities often arise from reagents which are critical to the synthesis therefore this impurity-related threat is unavoidable.

    As such, there is a need to assess the risk posed by mutagenic impurities.

    30 June 2021

  • 20 tips for nitrosamine impurity assessment

    20 tips for nitrosamine impurity assessment

    Many readers will be aware of the risk posed by nitrosamine impurities, as an ongoing pharmaceutical industry hot topic. In July 2021 ANVISA published their guidance for assessment and control of potentially carcinogenic nitrosamines in active pharmaceutical ingredients and drug products. To discuss this topic, we invited knowledgeable speakers from ANVISA, Industry - GSK and Libbs Farmacêutica - and Lhasa to give their perspectives on this topic. This article details the top 20 take away points from the workshop for quick and easy consumption - enjoy!

    05 August 2021

  • Effiris blog image Feb2021
    Clock: less than 5 minutesless than 5 minutes

    How to better anticipate and mitigate adverse drug reactions [an infographic]

    Are you interested in using your data to anticipate and mitigate adverse drug reactions? The Effiris consortium - currently composed of Takeda, GSK and UCB - is working to achieve just that.

    17 February 2021

  • Lhasa Limited is pleased to introduce the winner of the Richard Williams Memorial Award
    Clock: 5 minutes5 minutes

    Lhasa Limited is pleased to introduce the winner of the Richard Williams Memorial Award

    In July 2020, we announced the introduction of an annual award honouring the scientific contributions and memory of Dr. Richard Williams.

    It is with huge excitement that today, we are able to introduce you to the first winner of the Richard Williams Memorial Award, Amy Wilson. Amy is an Associate Principal Scientist within the Genetic Toxicology team at AstraZeneca. Learn more about Amy’s award-winning work, career to date, biggest inspiration and where you can see Amy present her work in this Q&A session – enjoy!

    06 May 2021

  • Moving with the times; Lhasa’s Cloud offerings
    Clock: less than 5 minutesless than 5 minutes

    Moving with the times; Lhasa’s cloud offerings

    In a world where we are all striving for progress, technology is also advancing quickly.

    Like many organisations across the life sciences industry – evidenced by the 82 Amazon Web Service (AWS) life sciences case studies -  Lhasa has adopted cloud, Software as a Service (SaaS), options across three notable areas...

    30 March 2021

  • Shaping Lhasa Limited’s scientific direction through collaboration
    Clock: less than 5 minutesless than 5 minutes

    Shaping Lhasa Limited’s scientific direction through collaboration

    “Our technology is designed by scientists, for scientists, in collaboration with industry stakeholders and regulators” …

    At Lhasa Limited we often talk about the importance of industry and regulatory input in shaping our scientific direction. This article discusses a few key areas of involvement and collaboration plus, focuses on a recent example, on the topic of Adverse Outcome Pathways (AOPs). Read on to learn more and find out how you can get involved!

    09 September 2021

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.